secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001522767-24-000063
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q2 2024 revenue $40.4M, GAAP net loss $1.6M, adjusted EBITDA $4.4M
--------------------------------------------------------------------------

- Revenue $40.4M, up 10.7% YoY from $36.5M; gross margin 42% (GAAP), 43% (non-GAAP).
- GAAP net loss $1.6M vs loss $0.9M in Q2 2023; non-GAAP net loss $0.2M vs income $0.6M.
- Non-GAAP adjusted EBITDA $4.4M (11% margin), down from $6.3M (17% margin) a year ago.
- Retail transactions increased 24% YoY; wholesale segment led overall growth.
- Management reaffirms 2024 financial targets; expects margin expansion and improved cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276724000063/0001522767-24-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276724000063/mrmd-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001522767-24-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer